The Hip Arthroplasty Positioning Improvement Study
HAPI
Does the Corin Optimised Positioning System Improve Clinical Outcome in Total Hip Arthroplasty? A Multi-centre, Two-arm Randomised Control Trial
1 other identifier
interventional
460
1 country
1
Brief Summary
The primary objective of this study is to determine whether the Corin Optimised Positioning System (Corin, U.K.) reduces the rate of hip dislocation at one-year post-operatively compared with standard templating in patients undergoing total hip replacement. The secondary objectives of this study are to determine whether the Corin Optimised Positioning System (Corin, U.K.) improves functional outcomes, reduces length of hospital stay, and reduces leg length discrepancy compared with standard templating in patients undergoing total hip replacement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 23, 2018
CompletedFirst Posted
Study publicly available on registry
June 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedMarch 29, 2019
May 1, 2018
3 years
May 23, 2018
March 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dislocation rate
Incidence of hip dislocation within 12 months post-operatively
12 months
Secondary Outcomes (10)
Change in Harris Hip Score
Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively
Change in Oxford Hip Score
Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively
Change in Hip and Groin Outcome Score
Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively
Change in International Hip Outcome Tool 33 (iHOT33) Score
Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively
Change in EuroQol 5 dimension (EQ5D) Score
Measured pre-operatively (baseline) and at 3, 6 and 12 months post-operatively
- +5 more secondary outcomes
Study Arms (2)
Corin OPS arm
EXPERIMENTALTotal hip replacement with use of Corin Optimised Positioning System to guide implant positioning
Standard care arm
ACTIVE COMPARATORTotal hip replacement with standard templating to guide implant positioning
Interventions
Total hip replacement with implant positioning guided by Corin Optimised Positioning System. The experimental and active comparator arms will use the same implants for total hip replacements. The Corin Trinity shell system will be used for the acetabular system. The Corin MiniHip, TriFit, MetaFix and TaperFit implants will be used for the femoral stem implant. Surgeons will select the implant most appropriate for each patient.
Total hip replacement with implant positioning guided by standard templating. The experimental and active comparator arms will use the same implants for total hip replacements. The Corin Trinity shell system will be used for the acetabular system. The Corin MiniHip, TriFit, MetaFix and TaperFit implants will be used for the femoral stem implant. Surgeons will select the implant most appropriate for each patient.
Eligibility Criteria
You may qualify if:
- Participant is willing and able to give informed consent for participation in the trial
- Diagnosed with hip OA, post-traumatic OA, inflammatory arthropathy, avascular necrosis, or congenital or developmental hip disease, avascular necrosis of the hip
- Listed for total hip arthroplasty at one of participating centres
- Participant is fit to undergo total hip arthroplasty based on consultant anaesthetist review
- In the Investigator's opinion, is able and willing to comply with all trial requirements
- Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial
- Female participants of child bearing potential must be willing to ensure that they use effective contraception during the trial
You may not qualify if:
- Inability to provide informed consent
- Previous surgery to the ipsilateral hip
- Significant co-morbidities that would make follow up difficult or uncomfortable
- Scheduled elective surgery or other procedures requiring general anaesthesia during the trial
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oxfordlead
- Corincollaborator
- Oxford University Hospitals NHS Trustcollaborator
Study Sites (1)
Nuffield Orthopaedic Centre, Oxford University Hospitals Trust
Oxford, OX3 7LD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sion Glyn-Jones, DPhil FRCS
University of Oxford
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants: participants in both arms will undergo total hip replacement while under general anaesthetic. Participants will not be aware of the templating method used during the total hip replacement due to the general anaesthetic, therefore will remain blinded. Wounds and dressings will be the same for both study arms. Participants in the two study arms will undergo the same pre- and post-operative imaging to prevent unmasking. Outcomes assessors examine patients from 3 months post-operatively. There is no risk they will know which arm the patient is in, as they will not have access to the study database.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2018
First Posted
June 18, 2018
Study Start
May 1, 2018
Primary Completion
May 1, 2021
Study Completion
May 1, 2022
Last Updated
March 29, 2019
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Data will be available within 6 months of study completion
- Access Criteria
- Data access requests will be reviewed by the trial steering committee. Requestors will be required to sign a data access agreement
De-identified individual participant data for all primary and secondary outcome measures will be made available.